Neurocrine Biosciences, Inc.
NBIX
$131.14
-$1.24-0.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.48B | 1.11B | 975.60M | 943.50M | 1.08B |
| Total Receivables | 686.80M | 728.00M | 595.70M | 516.00M | 479.10M |
| Inventory | 69.00M | 69.30M | 56.90M | 59.10M | 57.40M |
| Prepaid Expenses | 170.70M | 178.10M | -- | -- | 48.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 115.80M | 68.20M | 120.70M | 119.30M | 63.60M |
| Total Current Assets | 2.52B | 2.16B | 1.75B | 1.64B | 1.72B |
|
|
|||||
| Total Current Assets | 2.52B | 2.16B | 1.75B | 1.64B | 1.72B |
| Net Property, Plant & Equipment | 545.20M | 566.20M | 584.00M | 589.20M | 592.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 35.70M | 37.20M | 36.40M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 379.80M | 388.80M | 558.40M | 514.70M | 537.70M |
| Total Assets | 4.63B | 4.27B | 3.89B | 3.69B | 3.72B |
|
|
|||||
| Total Accounts Payable | 104.90M | 119.90M | 104.60M | 110.00M | 99.90M |
| Total Accrued Expenses | 501.40M | 464.40M | 359.20M | 339.80M | 351.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 56.00M | 51.30M | 50.70M | 45.60M | -- |
| Total Finance Division Other Current Liabilities | 81.10M | 2.40M | 31.80M | 27.50M | 56.10M |
| Total Other Current Liabilities | 81.10M | 2.40M | 31.80M | 27.50M | 56.10M |
| Total Current Liabilities | 743.40M | 638.00M | 546.30M | 522.90M | 507.70M |
|
|
|||||
| Total Current Liabilities | 743.40M | 638.00M | 546.30M | 522.90M | 507.70M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 415.30M | 428.40M | 439.10M | 447.50M | 455.10M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 219.70M | 195.70M | 210.10M | 181.60M | 166.20M |
| Total Liabilities | 1.38B | 1.26B | 1.20B | 1.15B | 1.13B |
|
|
|||||
| Common Stock & APIC | 2.79B | 2.70B | 2.60B | 2.53B | 2.55B |
| Retained Earnings | 447.70M | 294.00M | 84.50M | -5.30M | 29.20M |
| Treasury Stock & Other | 13.10M | 13.20M | 12.50M | 9.00M | 5.80M |
| Total Common Equity | 3.25B | 3.00B | 2.69B | 2.54B | 2.59B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.25B | 3.00B | 2.69B | 2.54B | 2.59B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.25B | 3.00B | 2.69B | 2.54B | 2.59B |
|
|
|||||